Albireo Pharma, Inc.

Albireo Pharma, Inc.verified

ALBO

Price:

$44.15

Market Cap:

$915.89M

Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as well as in Phase III clinical trial for treating biliary atresia, alagille syndrome, and rare and life-threatening disorder to children; and Elobixibat for the treatment of chronic constipation and other functional diseases. It also engages in the developing of A3907, which is in Phase I clinical trial for the treatment of adult liver diseases; and A234...[Read more]

Industry

Biotechnology

IPO Date

2007-05-11

Stock Exchange

NASDAQ

Ticker

ALBO

The PE Ratio as of June 2024 (TTM) for Albireo Pharma, Inc. (ALBO) is -6.63

According to Albireo Pharma, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -6.63. This represents a change of 45.78% compared to the average of -4.55 of the last 4 quarters.

Albireo Pharma, Inc. (ALBO) Historical PE Ratio (quarterly & annually)

How has ALBO PE Ratio performed in the past?

The mean historical PE Ratio of Albireo Pharma, Inc. over the last ten years is -3.06. The current -6.63 PE Ratio has changed 21.55% with respect to the historical average. Over the past ten years (40 quarters), ALBO's PE Ratio was at its highest in in the September 2021 quarter at 2.63. The PE Ratio was at its lowest in in the March 2018 quarter at -54.80.

Quarterly (TTM)
Annual

Average

-3.06

Median

-2.15

Minimum

-8.20

Maximum

-0.26

Albireo Pharma, Inc. (ALBO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Albireo Pharma, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 509.91%

Maximum Annual PE Ratio = -0.26

Minimum Annual Increase = -41.29%

Minimum Annual PE Ratio = -8.20

Quarterly (TTM)
Annual
YearPE RatioChange
2021-2.96-41.29%
2020-5.0414.26%
2019-4.41-29.17%
2018-6.23-24.07%
2017-8.20509.91%
2016-1.3426.18%
2015-1.0744.53%
2014-0.7487.13%
2013-0.3954.31%
2012-0.26-28.67%

Albireo Pharma, Inc. (ALBO) Average PE Ratio

How has ALBO PE Ratio performed in the past?

The current PE Ratio of Albireo Pharma, Inc. (ALBO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-4.14

5-year avg

-5.37

10-year avg

-3.06

Albireo Pharma, Inc. (ALBO) PE Ratio vs. Peers

How is ALBO’s PE Ratio compared to its peers?

Albireo Pharma, Inc.’s PE Ratio is

CompanyPE RatioMarket cap

Build a custom stock screener for Albireo Pharma, Inc. (ALBO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Albireo Pharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Albireo Pharma, Inc. (ALBO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Albireo Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Albireo Pharma, Inc.'s PE Ratio?

How is the PE Ratio calculated for Albireo Pharma, Inc. (ALBO)?

What is the highest PE Ratio for Albireo Pharma, Inc. (ALBO)?

What is the 3-year average PE Ratio for Albireo Pharma, Inc. (ALBO)?

What is the 5-year average PE Ratio for Albireo Pharma, Inc. (ALBO)?

How does the current PE Ratio for Albireo Pharma, Inc. (ALBO) compare to its historical average?